Michael S. Perry, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 36,000 shares at $36.42 ($1.3M) on 2020-05-12, disclosed to the SEC on 2020-05-13.
Open-market sale of $1.3M ARWR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.71 | 29,900 | $1.1M | 82.8% |
| 2 | $36.42 | 6,100 | $222K | 17.2% |
| Total | $35.83 avg | 36,000 | $1.3M | 100% |
| Filing → |
| RCEL | SELL | 2022-11-22 | $1.1M | — | Filing → |
| RCEL | SELL | 2022-02-25 | $189K | — | Filing → |
| ARWR | SELL | 2022-01-04 | $460K | — | Filing → |